Mechanism of cell death resulting fromDNAinterstrand cross-linking in mammalian cells

Cell Death and Disease

Volumn 2, Issue 8, 2011, Pages

  Osawa, T ^a,b   Davies, D ^c   Hartley, J A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF TOKYO   (Japan)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Apoptosis; Cell cycle arrest; Chromosomal abnormality; DNA cross link repair; DNA interstrand cross link; Homologous recombination

Indexed keywords

ANTINEOPLASTIC AGENT; CHLORMETHINE; DNA; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; PLATINUM; PROTEIN P53; XRCC3 PROTEIN; ALKYLATING AGENT; CHLORMETHINE DERIVATIVE; CROSS LINKING REAGENT; DNA BINDING PROTEIN; ENDONUCLEASE; ERCC1 PROTEIN, HUMAN; X-RAY REPAIR CROSS COMPLEMENTING PROTEIN 3;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL DEATH; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYTOKINESIS; DNA CROSS LINKING; DNA DAMAGE; HUMAN; HUMAN CELL; MAMMAL CELL; MICROSCOPY; MITOSIS; NONHUMAN; PRIORITY JOURNAL; TIME LAPSE IMAGING; ANIMAL; CHEMISTRY; CHO CELL; CRICETULUS; DNA REPAIR; DRUG EFFECT; HAMSTER; HELA CELL; METABOLISM; VIDEO MICROSCOPY;

BRASSICACEAE; MAMMALIA;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; APOPTOSIS; CHO CELLS; CHROMOSOME ABERRATIONS; CRICETINAE; CRICETULUS; CROSS-LINKING REAGENTS; DNA; DNA DAMAGE; DNA REPAIR; DNA-BINDING PROTEINS; ENDONUCLEASES; G2 PHASE; HELA CELLS; HUMANS; MICROSCOPY, VIDEO; NITROGEN MUSTARD COMPOUNDS; TIME-LAPSE IMAGING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 80052320476     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2011.70     Document Type: Article

References (41)

1. Hartley JA. Alkylating agents In:Souhami RL, Tannock I, Hohenberger P, Horiot J-C (eds) Oxford Textbook of Oncology. Oxford University Press: Oxford, UK, 2001, pp 639-654.
2. De Silva IU, McHugh PJ, Clingen PH, Hartley JA. Defining the roles of nucleotide excision repair and recombination in the repair of DNA interstrand cross-links in mammalian cells. Mol Cell Biol 2000; 20: 7980-7990.
3. McHugh PJ, Spanswick VJ, Hartley JA. Repair of DNA interstrand crosslinks: molecular mechanisms and clinical relevance. Lancet Oncol 2001; 2: 483-490. (Pubitemid 33586303)
4. O'Connor PM, Kohn KW. Comparative pharmacokinetics of DNA lesion formation and removal following treatment of L1210 cells with nitrogen mustards. Cancer Commun 1990; 2: 387-394.
5. Sunters A, Springer CJ, Bagshawe KD, Souhami RL, Hartley JA. The cytotoxicity, DNA crosslinking ability and DNA sequence selectivity of the aniline mustards melphalan, chlorambucil and 4-[bis(2-chloroethyl)amino] benzoic acid. Biochem Pharmacol 1992; 44: 59-64.
6. Spanswick VJ, Craddock C, Sekhar M, Mahendra P, Shankaranarayana P, Hughes RG et al. Repair of DNA interstrand crosslinks as a mechanism of clinical resistance to melphalan in multiple myeloma. Blood 2002; 100: 224-229. (Pubitemid 35177451)
7. Wynne P, Newton C, Ledermann JA, Olaitan A, Mould TA, Hartley JA. Enhanced repair of DNA interstrand crosslinking in ovarian cancer cells from patients following treatment with platinum-based chemotherapy. Br J Cancer 2007; 97: 927-933. (Pubitemid 47519316)
8. Ledermann JA, Gabra H, Jayson GC, Spanswick VJ, Rustin GJS, Jitlal M et al. Inhibition of carboplatin-induced DNA interstrand crosslink repair by gemcitabine in patients receiving these drugs for platinum-resistant ovarian cancer. Clinical Cancer Res 2010; 16: 4899-4905.
9. Dronkert ML, Kanaar R. Repair of DNA interstrand cross-links. Mutat Res 2001; 486: 217-247. (Pubitemid 32763210)
10. Gottesman MM. Mechanisms of cancer drug resistance. Annu Rev Med 2002; 53: 615-627. (Pubitemid 34177898)
11. Niedernhofer LJ, Odijk H, Budzowska M, van Drunen E, Maas A, Theil AF et al. The structure-specific endonuclease Ercc1-Xpf is required to resolve DNA interstrand crosslink- induced double-strand breaks. Mol Cell Biol 2004; 24: 5776-5787. (Pubitemid 38787963)
12. McHugh PJ, Sarkar S. DNA interstrand cross-link repair in the cell cycle: a critical role for polymerase zeta in G1 phase. Cell Cycle 2006; 5: 1044-1047. (Pubitemid 43765296)
13. Liu N, Lamerdin JE, Tebbs RS, Schild D, Tucker JD, Shen MR et al. XRCC2 and XRCC3, new human Rad51-family members, promote chromosome stability and protect against DNA cross-links and other damages. Mol Cell 1998; 1: 783-793. (Pubitemid 128379063)
14. Yu VP, Koehler M, Steinlein C, Schmid M, Hanakahi LA, van Gool AJ et al. Gross chromosomal rearrangements and genetic exchange between nonhomologous chromosomes following BRCA2 inactivation. Genes Dev 2000; 14: 1400-1406. (Pubitemid 30397083)
15. Grompe M, D'Andrea A. Fanconi anemia and DNA repair. Hum Mol Genet 2001; 10: 2253-2259. (Pubitemid 32998839)
16. Raschle M, Knipscheer P, Enoiu M, Angelov T, Sun J, Griffith JD et al. Mechanism of replication-coupled DNA interstrand crosslink repair. Cell 2008; 134: 969-980.
17. Hoeijmakers JH. Genome maintenance mechanisms for preventing cancer. Nature 2001; 411: 366-374. (Pubitemid 32467046)
18. Ben Yehoyada M, Wang LC, Kozekov ID, Rizzo CJ, Gottesman ME, Gautier J. Checkpoint signaling from a single DNA interstrand crosslink. Mol Cell 2009; 35: 704-715.
19. Zhou BB, Elledge SJ. The DNA damage response: putting checkpoints in perspective. Nature 2000; 408: 433-439.
20. Chen QM, Merrett JB, Dilley T, Purdom S. Downregulation of p53 with HPV E6 delays and modifies cell death in oxidant response of human diploid fibroblasts: an apoptosis-like cell death associated with mitosis. Oncogene 2002; 21: 5313-5324. (Pubitemid 34948142)
21. Castedo M, Perfettini JL, Roumier T, Andreau K, Medema R, Kroemer G. Cell death by mitotic catastrophe: a molecular definition. Oncogene 2004; 23: 2825-2837. (Pubitemid 38638845)
22. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456-1462.
23. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281: 1309-1312. (Pubitemid 28406816)
24. Andreassen PR, Lohez OD, Lacroix FB, Margolis RL. Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1. Mol Biol Cell 2001; 12: 1315-1328. (Pubitemid 33044413)
25. Ivanov A, Cragg MS, Erenpreisa J, Emzinsh D, Lukman H, Illidge TM. Endopolyploid cells produced after severe genotoxic damage have the potential to repair DNA double strand breaks. J Cell Sci 2003; 116: 4095-4106. (Pubitemid 37337084)
26. Hartley JM, Spanswick VJ, Gander M, Giacomini G, Whelan J, Souhami RL et al. Measurement of DNA cross-linking in patients on ifosfamide therapy using the single cell gel electrophoresis (comet) assay. Clin Cancer Res 1999; 5: 507-512. (Pubitemid 29131958)
27. Sun XM, MacFarlane M, Zhuang J, Wolf BB, Green DR, Cohen GM. Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J Biol Chem 1999; 274: 5053-5060.
28. Chu K, Leonhardt EA, Trinh M, Prieur-Carrillo G, Lindqvist J, Albright N et al. Computerized video time-lapse (CVTL) analysis of cell death kinetics in human bladder carcinoma cells (EJ30) X-irradiated in different phases of the cell cycle. Radiat Res 2002; 158: 667-677. (Pubitemid 35429961)
29. Huang H, Fletcher L, Beeharry N, Daniel R, Kao G, Yen TJ et al. Abnormal cytokinesis after X-irradiation in tumor cells that override the G2 DNA damage checkpoint. Cancer Res 2008; 68: 3724-3732.
30. Tang DG, Tokumoto YM, Apperly JA, Lloyd AC, Raff MC. Lack of replicative senescence in cultured rat oligodendrocyte precursor cells. Science 2001; 291: 868-871. (Pubitemid 32120756)
31. Billon N, Terrinoni A, Jolicoeur C, McCarthy A, Richardson WD, Melino G et al. Roles for p53 and p73 during oligodendrocyte development. Development 2004; 131: 1211-1220. (Pubitemid 38443876)
32. McHugh PJ, Sones WR, Hartley JA. Repair of intermediate structures produced at DNA interstrand cross-links in Saccharomyces cerevisiae. Mol Cell Biol 2000; 20: 3425-3433. (Pubitemid 30243888)
33. Brozovic A, Damrot J, Tsaryk R, Helbig L, Nikolova T, Hartig C et al. Cisplatin sensitivity is related to late DNA damage processing and checkpoint control rather than to the early DNA damage response. Mutat Res 2009; 670: 32-41.
34. Zong WX, Ditsworth D, Bauer DE, Wang ZQ, Thompson CB. Alkylating DNA damage stimulates a regulated form of necrotic cell death. Genes Dev 2004; 18: 1272-1282. (Pubitemid 38720595)
35. Ganem NJ, Storchova Z, Pellman D. Tetraploidy, aneuploidy and cancer. Curr Opin Genet Dev 2007; 17: 157-162. (Pubitemid 46551722)
36. Brathen M, Banrud H, Berg K, Moan J. Induction of multinucleated cells caused by UVA exposure in different stages of the cell cycle. Photochem Photobiol 2000; 71: 620-626.
37. Illidge TM, Cragg MS, Fringes B, Olive P, Erenpreisa JA. Polyploid giant cells provide a survival mechanism for p53 mutant cells after DNA damage. Cell Biol Int 2000; 24: 621-633.
38. Sneige N, Kemp B, Pusztai L, Asmar L, Hortobagyi GN. Chemotherapy-induced histologic changes in mastectomy specimens and their potential significance. Breast 2001; 10: 492-500. (Pubitemid 33150364)
39. Kasiappan R, Shih HJ, Chu KL, Chen WT, Liu HP, Huang SF et al. Loss of p53 and MCT-1 overexpression synergistically promote chromosome instability and tumorigenicity. Mol Cancer Res 2009; 7: 536-548.
40. Frey T. Nucleic acid dyes for detection of apoptosis in live cells. Cytometry 1995; 21: 265-274.
41. Kanda T, Sullivan KF, Wahl GM. Histone-GFP fusion protein enables sensitive analysis of chromosome dynamics in living mammalian cells. Curr Biol 1998; 8: 377-385. (Pubitemid 28173996)